Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Clinical trial NCT05905770 · UNKNOWN

Trial details

NCT number: NCT05905770
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: UNKNOWN
Study type: OBSERVATIONAL

Sickle Cell Disease

Start date: 2022-07-15
Primary completion: 2024-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.